|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date08 Apr 1996 |
|
|
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.US |
First Approval Date23 Jun 2005 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Galen US, Inc.
0 Patents (Medical) associated with Galen US, Inc.
100 Deals associated with Galen US, Inc.
100 Translational Medicine associated with Galen US, Inc.